Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists

Indications for Interferon/Ribavirin Therapy in Hepatitis C Patients: Findings from a Survey of Canadian Hepatologists

OBJECTIVE: To survey practising hepatologists about their attitudes and practices regarding interferon and ribavirin combination therapy for hepatitis C (HCV) patients in Canada.

Saved in:

Bibliographic Details
Main Authors:	Peter Wang, Qilong Yi, Linda Scully, Jenny Heathcote, Murray Krahn
Format:	Article
Language:	English
Published:	Wiley 2003-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/2003/498120
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Percutaneous Liver Biopsy Practice Patterns Among Canadian Hepatologists
by: Mohammed Aljawad, et al.
Published: (2013-01-01)

Efficacy and safety of triple therapy with recombinant interleukin-1β, recombinant interferon-α and ribavirin in patients with chronic hepatitis C, genotype 1 infection, the non-responders to previous treatment with interferon and ribavirin
by: Yu. V. Lobzin, et al.
Published: (2014-09-01)

Sequence variation of the HVR1 region of Hepatitis C virus in response to interferon-α and ribavirin treatment
by: Ahmed Ali Al-Qahtani, et al.
Published: (2011-05-01)

Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients
by: Konstantinos D. Pantazis, et al.
Published: (2008-01-01)

Hepatitis C Eradication and Improvement of Cryoglobulinemia-Associated Rash and Membranoproliferative Glomerulonephritis with Interferon and Ribavirin after Kidney Transplantation
by: Marilyn Zeman, et al.
Published: (2006-01-01)

İnterferon ve ribavirin tedavisiyle gelişen plevral efüzyon
by: Aziz Öğütlü, et al.
Published: (2015-09-01)

Autoimmune manifestation of hepatitis C virus infection as a risk for late virological relapse after pegylated interferon and ribavirin therapy
by: Ružić Maja, et al.
Published: (2018-01-01)

Autophagy: A Primer for the Gastroenterologist/Hepatologist
by: Christiane Sokollik, et al.
Published: (2011-01-01)

Pleuro-Pulmonary Nocardiosis as Opportunistic Infection in a Patient with Chronic Hepatitis C under Combination Treatment with Pegylated Interferon, Ribavirin, and Boceprevir
by: Csilla Putz-Bankuti, et al.
Published: (2013-01-01)

Response to Pegylated Interferon Plus Ribavirin in Patients with Hepatitis C Virus Genotype 6a Infection from Guangdong and Guangxi Province of China
by: Wangxia Tong, et al.
Published: (2016-01-01)

The Impact Of Hepatitis B Knowledge and Stigma on Screening in Canadian Chinese Persons
by: Dorothy Li, et al.
Published: (2012-01-01)

Long Term Follow-Up of Patients with Chronic Hepatitis C Treated with Alpha Interferon
by: Jane D Collier, et al.
Published: (2000-01-01)

Modeling Ribavirin‐Induced Anemia in Patients with Chronic Hepatitis C Virus
by: LS Wu, et al.
Published: (2016-02-01)

Anti-Hepatitis C Activity of Combination of Ruta angustifolia Extract and Ribavirin
by: Tutik Sri Wahyuni, et al.
Published: (2022-08-01)

Role of microRNA modulation in the interferon-α/ribavirin suppression of HIV-1 in vivo.
by: Mohamed Abdel-Mohsen, et al.
Published: (2014-01-01)

Sociocultural Factors That Potentially Affect the Institution of Prevention and Treatment Strategies for Hepatitis B in Chinese Canadians
by: Harry Wu, et al.
Published: (2009-01-01)

Does a Rapid Decline in the Hematological and Biochemical Parameters Induced by Interferon and Ribavirin Combination Therapy for the Hepatitis C Virus Predict a Sustained Viral Response?
by: Christian Turbide, et al.
Published: (2008-01-01)

Evaluation of ribavirin efficacy and tolerance in subjects with chronic hepatitis C virus infection
by: Stanimirović Violeta, et al.
Published: (2002-01-01)

Treatment of chronic hepatitis C by cepeginterferon alpha-2b in combination to ribavirin
by: M. V. Mayevskaya, et al.
Published: (2014-08-01)

The combined therapy of chronic hepatitis with pegilated interferon <i>a</i>-2а and ribavirin in patients with HIV-infection and patients with HCV monoinfection
by: N. D. Yuschuk, et al.
Published: (2009-02-01)

The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era
by: Sonya A MacParland, et al.
Published: (2014-01-01)

Palliative Management of Advanced Pancreatic Cancer: The Role of Gastroentero-hepatologist
by: Randy Adiwinata, et al.
Published: (2020-08-01)

Palliative Management of Advanced Pancreatic Cancer: The Role of Gastroentero-hepatologist
by: Randy Adiwinata, et al.
Published: (2020-08-01)

Multidisciplinary approach as a model for detection and monitoring of psichiatric morbidity in patients treated with interferon and ribavirin
by: M. Cabré Serres, et al.
Published: (2014-05-01)

Treatment of anicteric acute hepatitis C with peginterferon alpha-2a plus ribavirin
by: Delić Dragan, et al.
Published: (2005-01-01)

Efficacy of Sofosbuvir and Ribavirin in Children Presenting with Hepatitis C at Tertiary Care Hospital, Faisalabad
by: Nagina Shahzadi, et al.
Published: (2023-04-01)

EFFICACY AND SAFETY OF THE COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON ALFA-2A IN PATIENTS WITH CHRONIC HEPATITIS C: THE RESULTS OF TWO MULTICENTER, PROSPECTIVE, OPEN, NON-COMPARATIVE CLINICAL TRIALS
by: K. V. Zhdanov, et al.
Published: (2018-01-01)

PEG-Interferon-α ribavirin-induced HCV viral clearance: a pharmacogenetic multicenter Spanish study
by: Javier Milara, et al.
Published: (2015-01-01)

Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated Interferon
by: Piotr Milkiewicz, et al.
Published: (2005-01-01)

Investigating Human Liver Tissue-Resident Memory T Cells from the Perspectives of Gastroenterologists and Hepatologists
by: Ji Won Han, et al.
Published: (2025-03-01)

Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Has the Time Come for Cardiologists to Be Hepatologists?
by: Mohamed H. Ahmed, et al.
Published: (2012-01-01)

A Case of Giant Cell Hepatitis Recurring after Liver Transplantation and Treated with Ribavirin
by: Ziad Hassoun, et al.
Published: (2000-01-01)

The efficacy and safety of double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alfa 2b and ribavirin) treatment regimens in chronic hepatitis C patients. The experience of everyday clinical practice
by: N. P. Blokhina, et al.
Published: (2016-07-01)

Ribavirin therapy for Chikungunya arthritis
by: Rajan Ravichandran, et al.
Published: (2008-04-01)

Health State Utilities and Quality of Life in Patients with Hepatitis B
by: Gloria Woo, et al.
Published: (2012-01-01)

Early virologic response to сеpeginterferon alfa-2b in combination with ribavirin in treatment of patients with chronic hepatitis C
by: O. O. Znoyko, et al.
Published: (2014-09-01)

Physicians’ Attitudes and Practice Toward Treating Injection Drug Users Infected with Hepatitis C Virus: Results from a National Specialist Survey in Canada
by: Angelique Myles, et al.
Published: (2011-01-01)

The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study
by: Juferdy Kurniawan, et al.
Published: (2019-08-01)

The Role of Hepatitis C Virus NS5A Region Mutation and SNP IL-28B of Host to Support Successful Pegylated Interferon and Ribavirin Treatment in Patients with HCV-HIV Coinfection: A Prospective Cohort Study
by: Juferdy Kurniawan, et al.
Published: (2019-08-01)

An Efficient Chemoenzymatic Process for Preparation of Ribavirin
by: Vladimir Sakharov, et al.
Published: (2015-01-01)